Skip to content

Routine magnifying endoscopy examine mode verse white light endoscopy based examine mode for opportunistic screening on early carcinoma and precancerous lesions of upper digestive tract: a multicenter clinical study

Routine magnifying endoscopy examine mode verse white light endoscopy based examine mode for opportunistic screening on early carcinoma and precancerous lesions of upper digestive tract: a multicenter clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064174
Enrollment
Unknown
Registered
2022-09-29
Start date
2022-09-29
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early carcinoma and precancerous lesions of upper digestive tract

Interventions

group 1 white light endoscopy :blank controled group
group 2 white light endoscopy and magnifying endoscopy if necessary:change to a magnifying endoscopy if necessary
group 3 routine-use of magnifying endoscopy :use the magnifying endoscopy during the hole examination

Sponsors

Second Affiliated Hospital of Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Male or female aged at least 18 years; 2. Volunteered to participate in the clinical study, and signed the informed consent before surgery.

Exclusion criteria

Exclusion criteria: 1. Endoscopy could not be performed for the patient's own reason; (e.g., those with severely impaired function of vital organs such as heart, lung, brain, or kidney and hematopoiesis, accompanied by mental illness); 2. Pregnant, lactating female patients; 3. Patients with mental illness and Patients who could not cooperate during the examination; 4. Sever active infections, etc., which was inappropriate to examination; 5. Patients who were unwilling to join this experiment, refused to sign the informed consent form or comprehensive judgment of poor compliance.

Design outcomes

Primary

MeasureTime frame
detection rate;

Secondary

MeasureTime frame
Coincidence rate of endoscopic diagnosis and pathological diagnosis;

Countries

China

Contacts

Public ContactJianying Bai

Second Affiliated Hospital of Army Military Medical University

Drbaijy2015@163.com+86 15002378878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026